相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Function and proteolytic generation of the soluble interleukin-6 receptor in health and disease
Tim Schumertl et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2022)
Dexmedetomidine as an Analgesic Agent with Neuroprotective Properties: Experimental and Clinical Aspects
Hooman Bozorgi et al.
JOURNAL OF PAIN & PALLIATIVE CARE PHARMACOTHERAPY (2021)
Dexmedetomidine inhibits apoptosis of astrocytes induced by oxygen-glucose deprivation via targeting JAK/STAT3 signal pathway
Pengjiu Feng et al.
BRAIN RESEARCH (2021)
The potential role of dexmedetomidine on neuroprotection and its possible mechanisms: Evidence from in vitro and in vivo studies
Kantarakorn Unchiti et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2021)
The involvement of JAK/STAT signaling pathway in the treatment of Parkinson's disease
Naser-Aldin Lashgari et al.
JOURNAL OF NEUROIMMUNOLOGY (2021)
Understanding the Connection Between Common Stroke Comorbidities, Their Associated Inflammation, and the Course of the Cerebral Ischemia/Reperfusion Cascade
Lukasz Przykaza
FRONTIERS IN IMMUNOLOGY (2021)
The effect of dexmedetomidine on liver injury secondary to lower extremity ischemia-reperfusion in a diabetic rat model
Seyfi Kartal et al.
CLINICAL AND EXPERIMENTAL HYPERTENSION (2021)
The bidirectional role of the JAK2/STAT3 signaling pathway and related mechanisms in cerebral ischemia-reperfusion injury
Yi Zhong et al.
EXPERIMENTAL NEUROLOGY (2021)
Distinctive effect of anesthetics on the effect of limb remote ischemic postconditioning following ischemic stroke
Gangling Chen et al.
PLOS ONE (2020)
The Role of Janus Kinase/Signal Transducer and Activator of Transcription Signalling on Preventing Intestinal Ischemia/Reperfusion Injury with Dexmedetomidine
Xuekang Zhang et al.
JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY (2020)
How Long Are Reperfusion Therapies Beneficial for Patients after Stroke Onset? Lessons from Lethal Ischemia Following Early Reperfusion in a Mouse Model of Stroke
Takayuki Nakagomi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Would Colloidal Gold Nanocarriers Present An Effective Diagnosis Or Treatment For Ischemic Stroke?
Hamed Amani et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2019)
Blocking interleukin-6 trans-signaling protects against renal fibrosis by suppressing STAT3 activation
Wei Chen et al.
THERANOSTICS (2019)
Targeting vascular inflammation in ischemic stroke: Recent developments on novel immunomodulatory approaches
Shashank Shekhar et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2018)
Advances in stroke pharmacology
Zhenhua Zhou et al.
PHARMACOLOGY & THERAPEUTICS (2018)
The molecular details of cytokine signaling via the JAK/STAT pathway
Rhiannon Morris et al.
PROTEIN SCIENCE (2018)
Dexmedetomidine confers neuroprotection against transient global cerebral ischemia/reperfusion injury in rats by inhibiting inflammation through inactivation of the TLR-4/NF-κB pathway
Eugene Kim et al.
NEUROSCIENCE LETTERS (2017)
Different doses of dexmedetomidine reduce plasma cytokine production, brain oxidative injury, PARP and caspase expression levels but increase liver oxidative toxicity in cerebral ischemia-induced rats
Orhan Akpinar et al.
BRAIN RESEARCH BULLETIN (2017)
Dexmedetomidine promotes the recovery of the field excitatory postsynaptic potentials (fEPSPs) in rat hippocampal slices exposed to oxygen-glucose deprivation
Sung-Eun Kim et al.
NEUROSCIENCE LETTERS (2016)
The IL-6/gp130/STAT3 signaling axis: recent advances towards specific inhibition
Christoph Garbers et al.
CURRENT OPINION IN IMMUNOLOGY (2015)
Molecular targets and mechanism of action of dexmedetomidine in treatment of ischemia/reperfusion injury (Review)
Ye Cai et al.
MOLECULAR MEDICINE REPORTS (2014)
JAK2 and STAT3 activation contributes to neuronal damage following transient focal cerebral ischemia
Irawan Satriotomo et al.
JOURNAL OF NEUROCHEMISTRY (2006)